Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 38 for “"alteplase"”.

  1. Tenecteplase and alteplase in acute ischaemic stroke thrombolysis: clinical and imaging study

    … thrombolysis in acute ischaemic stroke with alteplase improves clinical outcomes, but it has limited efficacy and is associated with increased risk of intracranial haemorrhage. An improved tissue plasminogen activator, tenecteplase, was evidenced to be at least equally effective with lower …

    glasgow Download PDF for Tenecteplase and alteplase in acute ischaemic stroke thrombolysis: clinical and imaging study (opens in a new tab)

  2. Cost analysis : switching from alteplase to tenecteplase for management of acute ischemic stroke

    … neurological function within three months. Alteplase is a tPA approved for the treatment of AIS and is widely studied. Tenecteplase is another tPA approved for the treatment of Acute Myocardial Infarction (AMI) but not AIS. Although tenecteplase is not FDA-approved for AIS, it has …

    texas Repository record for Cost analysis : switching from alteplase to tenecteplase for management of acute ischemic stroke (opens in a new tab)

  3. Predicting the Risk of Intracerebral Haemorrhage in Patients with Acute Ischemic Stroke Receiving IV-alteplase with or Without Endovascular Thrombectomy

    Intracerebral Haemorrhage (ICH) is a devastating complication of acute ischemic stroke (AIS) treatment with no known effective management protocols. The need to identify patients at risk of developing this condition is becoming increasingly recognized among the stroke community. Computed tomography …

    calgary Repository record for Predicting the Risk of Intracerebral Haemorrhage in Patients with Acute Ischemic Stroke Receiving IV-alteplase with or Without Endovascular Thrombectomy (opens in a new tab)

  4. Effects of low-dose alteplase and intensive blood pressure control on brain (micro-) circulation: imaging analyses from the ENCHANTED trial

    … the effects of treatment with either intravenous alteplase by dose or in the control of blood pressure (BP) according to intensity. Methods: Secondary analyses of datasets from the international randomised trial - Enhanced Control of Hypertension and Thrombolysis Stroke Study (ENCHANTED) - were …

    unsw Repository record for Effects of low-dose alteplase and intensive blood pressure control on brain (micro-) circulation: imaging analyses from the ENCHANTED trial (opens in a new tab)

  5. Optimizing the management of hemodialysis catheter occlusion

    … the cost of care. Repeated administration of alteplase in hemodialysis catheters typically produces only short-term benefits. The purpose of this study was to design, implement and evaluate the efficacy of a step-by-step algorithm to optimize the management of hemodialysis catheter occlusion. …

    manitoba Repository record for Optimizing the management of hemodialysis catheter occlusion (opens in a new tab)

  6. Optimising outcomes of intravenous thrombolysis in acute ischaemic stroke

    … to be a superior thrombolytic drug to alteplase • Improved patient selection through CT perfusion studies identifying groups at risk of poor outcome or greater benefit • The effect of patient heterogeneity on outcomes in trials of acute ischaemic stroke Tenecteplase is emerging as an …

    glasgow Repository record for Optimising outcomes of intravenous thrombolysis in acute ischaemic stroke (opens in a new tab) Download PDF for Optimising outcomes of intravenous thrombolysis in acute ischaemic stroke (opens in a new tab)

  7. Mean Arterial Pressure in Acute Ischemic Stroke Study

    … Today, 25 years after the FDA’s approval of alteplase, practitioners continue to use BP parameters of 185/110 and 180/105 to guide the initiation of alteplase bolus and infusion, although the shift to the use of NIBP devices challenges the validity of these dated parameters. Theoretically, by …

    tenn-hsc Repository record for Mean Arterial Pressure in Acute Ischemic Stroke Study (opens in a new tab)

  8. Novel insights into the assessment and therapeutics of microcirculatory injury in acute myocardial infarction

    … insights into the effects of intracoronary alteplase on the microcirculation. Methods: The first part of the thesis sought to establish the influence of coronary flow on the effects of adjunctive intracoronary alteplase, and to investigate the effects of intracoronary alteplase on invasive …

    glasgow Repository record for Novel insights into the assessment and therapeutics of microcirculatory injury in acute myocardial infarction (opens in a new tab) Download PDF for Novel insights into the assessment and therapeutics of microcirculatory injury in acute myocardial infarction (opens in a new tab)

  9. Imaging-guided thrombolysis for acute ischemic lacunar stroke past 4.5 hours

    … for acute ischemic stroke, intravenous alteplase may be used within 3-4.5 hours of symptom recognition or in cases of unknown onset if there is a small lesion on diffusion weighted imaging without increased signal on FLAIR sequence MRI. We seek to determine whether patients with lacunar …

    bu Repository record for Imaging-guided thrombolysis for acute ischemic lacunar stroke past 4.5 hours (opens in a new tab)

  10. Saving the Brain Matter(s): Improving Stroke Outcomes Utilizing a Direct to CT Workflow

    … ischemic stroke patients eligible for potential alteplase treatment was increase from one nurse to two nurses until the decision to use or not use alteplase was made. After the interdisciplinary team developed the workflow over 140 healthcare professionals from multiple departments were educated …

    usfca Repository record for Saving the Brain Matter(s): Improving Stroke Outcomes Utilizing a Direct to CT Workflow (opens in a new tab)

  11. Drip and Ship versus Mothership: Transportation and Treatment Strategies for Acute Ischemic Stroke Patients

    … with large vessel occlusion can be treated with alteplase and/or endovascular therapy. While endovascular therapy has been proven more effective than alteplase the administration of both treatments is highly time sensitive. There are geographic disparities in access to endovascular therapy. For …

    calgary Repository record for Drip and Ship versus Mothership: Transportation and Treatment Strategies for Acute Ischemic Stroke Patients (opens in a new tab)

  12. Improving the Care for Acute Ischemic Stroke Patients

    … well-being. The clinical benefit of intravenous Alteplase for ischemic stroke patients results in better outcomes. Intravenous thrombolysis success is dependent on narrowing time to treat (Fonarow et al., 2014). Decreasing the time to intravenous thrombolysis for acute ischemic stroke patients …

    usfca Repository record for Improving the Care for Acute Ischemic Stroke Patients (opens in a new tab)

  13. Imaging intracranial arterial patency and intravenous thrombolysis in acute ischaemic stroke

    … trial testing the use of intravenous alteplase for the acute treatment of ischaemic stroke. I begin by summarising the main features of stroke, covering techniques for imaging the brain and for imaging arterial patency, and post-stroke outcomes. Next I describe two literature reviews …

    edinburgh Repository record for Imaging intracranial arterial patency and intravenous thrombolysis in acute ischaemic stroke (opens in a new tab)

  14. Improving Stroke Documentation on a Stroke Unit

    … which were patients who either received alteplase (TPA= 19); did not receive alteplase (NTPA= 34); had Intracerebral Hemorrhagic Stroke (ICH= 30); or were suspected of stroke/ Transient Ischemic Attack (TIA= 15). Next, stroke chart audits were done to determine whether or not the nursing …

    usfca Repository record for Improving Stroke Documentation on a Stroke Unit (opens in a new tab)

  15. Predicted risk of harm versus treatment benefit in large randomised controlled trials

    … treatment with aspirin and treatment with alteplase have both proven to be effective in reducing the odds of death or dependency in follow-up. However, in both cases, treated patients are subject to a greater risk of haemorrhage – a serious side-effect which could result in early death or …

    edinburgh Repository record for Predicted risk of harm versus treatment benefit in large randomised controlled trials (opens in a new tab)

  16. The Impact of Geographic Deprivation Levels on Acute Ischemic Stroke Care in Alberta

    … Database. All patients were treated with IV Alteplase between January 1, 2017, and December 31, 2019. The outcomes of interest were treatment with endovascular thrombectomy (EVT), patient outcome (home-time), and treatment acuity (emergency room triage scores and stroke to needle time). Our …

    calgary Repository record for The Impact of Geographic Deprivation Levels on Acute Ischemic Stroke Care in Alberta (opens in a new tab)

  17. Use of thrombolytic therapy beyond current recommendations for acute ischaemic stroke

    … recommended for exclusions from receiving alteplase for acute ischaemic stroke. In Chapter 3, I examine Virtual International Stroke Trials Archive (VISTA) data to test whether current European recommendation suggesting exclusion of elderly patients (older than 80 years) from thrombolysis …

    glasgow Download PDF for Use of thrombolytic therapy beyond current recommendations for acute ischaemic stroke (opens in a new tab)

  18. Syngene Transplantation regenerativer Fettgewebszellen nach experimentellem Schlaganfall in der spontanhypertensiven Ratte

    … des Apoplex besteht aus der Lysetherapie mit Alteplase. Diese ist jedoch nur zeitlich beschränkt einsetzbar und birgt Risiken. Neue Behandlungsansätze zur Heilung des Schlaganfalles, wie zum Bespiel medikamentöse Neuroprotektiva oder Zelltherapien, zeigten vielversprechende Ergebnisse in …

    qucosa-diss

  19. Komplexität des Ischämischen Schlaganfalls am Beispiel der Analyse verschiedener Einflussfaktoren auf das Outcome

    … Blutung nach intravenöser Applikation von Alteplase haben was nicht dazu führen darf, dass per se diesen Patienten diese evidenzbasierte Therapie vorenthalten sollte. Vielmehr sollte die Nierenfunktionsstörung als entsprechenden Risikofaktor in der Risiko-Nutzen-Abwägung in Betracht gezogen …

    fu-berlin Repository record for Komplexität des Ischämischen Schlaganfalls am Beispiel der Analyse verschiedener Einflussfaktoren auf das Outcome (opens in a new tab)

Page 1 of 2